Macular degeneration

Aflibercept in AMD: no proof of added benefit

Manufacturer’s dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit… Read More ›

Scientists successfully awaken sleeping stem cells: ” might be possible to turn on the eye’s own resources to regenerate damaged retinas, without the need for transplanting outside retinal tissue or stem cells,”

Contact: Patti Jacobs pjacobs12@comcast.net 617-868-0077 Schepens Eye Research Institute New hope for regenerating the human retina damaged by disease or injury Boston, MA—Scientists at Schepens Eye Research Institute have discovered what chemical in the eye triggers the dormant capacity of… Read More ›